Detection of locoregional recurrent head and neck cancer after (chemo)radiotherapy using modern imaging

Oral Oncology

Volumn 45, Issue 4-5, 2009, Pages 386-393

  de Bree, Remco ^a   Putten, Lisa van der ^a   Brouwer, Jolijn ^a   Castelijns, Jonas A ^a   Hoekstra, Otto S ^a   Rene Leemans C ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Chemoradiation; FDG PET, CT, MRI; Head and neck cancer; Radiotherapy; Recurrence

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE F 18;

BIOPSY; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DIFFUSION WEIGHTED IMAGING; ELECTRIC POTENTIAL; GENERAL ANESTHESIA; HEAD AND NECK CANCER; HEALTH CARE; HUMAN; HYPOPHARYNX CARCINOMA; LARYNGOSCOPY; LARYNX CARCINOMA; MOUTH CANCER; NECK DISSECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; OROPHARYNX CANCER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION; RECURRENT CANCER; RECURRENT DISEASE; REVIEW; SCORING SYSTEM; SURGICAL TECHNIQUE;

DIFFUSION MAGNETIC RESONANCE IMAGING; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; LARYNGEAL NEOPLASMS; MAGNETIC RESONANCE IMAGING; MOUTH NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; OROPHARYNGEAL NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIOPHARMACEUTICALS; RECURRENCE; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 67349214957     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2008.10.015     Document Type: Review

References (63)

1. Alkureishi L.W.T., de Bree R., and Ross G.L. RADPLAT: an alternative to surgery?. Oncologist 11 (2006) 469-480
2. Bahadur S., Amatya R.C., and Kacker S.K. The enigma of post-radiation oedema and residual or recurrent carcinoma of the larynx and pyriform sinus. J Laryngol Otol 99 (1985) 763-765
3. O'Brien P.C. Tumour recurrence or treatment sequelae following radiotherapy for larynx cancer. J Surg Oncol 63 (1996) 130-135
4. 18F]Fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma. J Clin Oncol 20 (2002) 4199-4208
5. Klabbers B.M., Lammertsma A.A., and Slotman B.J. The value of positron emission tomography for monitoring response to radiotherapy in head and neck cancer. Mol Imaging Biol 5 (2003) 257-270
6. McCollum A.D., Burrell S.C., Haddad R.I., Norris C.M., Tishler R.B., Case M.A., et al. Positron emission tomography with 18F-fluorodeoxyglucose to predict pathologic response after induction chemotherapy and definitive chemoradiotherapy in head and neck cancer. Head Neck 26 (2004) 890-896
7. Kitagawa Y., Nishizawa S., Sano K., Ogasawara T., Nkamura M., Sadato N., et al. Prospective comparison of 18F-FDG PET with conventional imaging modalities (MRI, CT, and 67Ga scintigraphy) in assessment of combined intraarterial chemotherapy and radiotherapy for head and neck carcinoma. J Nucl Med 44 (2003) 198-206
8. Chen A.Y., Vilaseca I., Hudgins P.A., Schuster D., and Halkar R. PET-CT vs contrast-enhanced CT: what is the role for each after chemoradiation for advanced oropharyngeal cancer?. Head Neck 28 (2006) 487-495
9. Ryan W.R., Fee Jr. W.E., Le Q.T., and Pinto H.A. Positron-emission tomography for surveillance of head and neck cancer. Laryngoscope 115 (2005) 645-650
10. Yao M., Graham M.M., Smith R.B., Dornfeld K.J., Swkarchuk M., Hoffman H.T., et al. Value of FDG PET in assessment of treatment response and surveillance in head-and-neck cancer patients after intensity modulated radiation treatment: a preliminary report. Int J Radiat Oncol Biol Phys 60 (2004) 1410-1418
11. Conessa C., Herve S., Foehrenbach H., and Poncet J.L. FDG-PET scan in local follow-up of irradiated head and neck squamous cell carcinomas. Ann Otol Rhinol Laryngol 113 (2004) 628-635
12. Fischbein N.J., AAssar O.S., Caputo G.R., Kaplan M.J., Singer M.I., Price D.C., et al. Clinical utility of positron emission tomography with 18F-fluorodeoxyglucose in detecting residual/recurrent squamous cell carcinoma of the head and neck. AJNR Am J Neuroradiol 19 (1998) 1189-1196
13. Farber L.A., Benard F., Machtay M., Smith R.J., Weber R.S., Weinstein G.S., et al. Detection of recurrent head and neck squamous cell carcinomas after radiation therapy with 2-18F-fluoro-2-deoxy-d-glucose positron emission tomography. Laryngoscope 109 (1999) 970-975
14. Hanasono M.M., Kunda L.D., Segall G.M., Ku G.H., and Terris D.J. Uses and limitations of FDG positron emission tomography in patients with head and neck cancer. Laryngoscope 109 (1999) 880-885
15. 18FDG PET scans 1 month after completing radiotherapy of squamous cell carcinoma of the head and neck. J Nucl Med 48 (2007) 373-378
16. Fakhry N., Barberet M., Paris J., Jacob T., Deveze A., Mundler O., et al. Contribution of 18FDG PET/CT post treatment surveillance of head and neck squamous cell carcinoma. Ann Otolaryngol Chir Cervicofac 123 (2006) 167-174
17. Rogers J.W., Greven K.M., McGuirt W.F., Keyes Jr. J.W., Williams III D.W., Watson N.E., et al. Can post-RT neck dissection be omitted for patients with head-and-neck cancer who have a negative PET scan after definitive radiation therapy?. Int J Radiat Oncol Biol Phys 58 (2004) 694-697
18. Gourin C.G., Williams H.T., Seabolt W.N., Herdman A.V., Howington J.W., and Terris D.J. Utility of positron emission tomography-computed tomography in identification of residual nodal disease after chemoradiation for advanced head and neck cancer. Laryngoscope 116 (2006) 705
19. Brkovich V.S., Miller F.R., Karnad A.B., Hussey D.H., McGuff H.S., and Otto R.A. The role of positron emission tomography scans in the management of the N-positive neck in head and neck squamous cell carcinoma after chemoradiotherapy. Laryngoscope 116 (2006) 855-858
20. Porceddu S.V., Jarmolowski E., Hicks R.J., Ware R., Weih L., Rischin D., et al. Utility of positron emission tomography for the detection of disease in residual neck nodes after (chemo)radiotherapy in head and neck cancer. Head Neck 27 (2005) 175-181
21. Yao M., Smith R.B., Graham M.M., Hoffman H.T., Tan H., Funk G.F., et al. The role of FDG PET in management of neck metastasis from head-and-neck cancer after definitive radiation treatment. Int J Radiat Oncol Biol Phys 15 63 (2005) 991-999
22. Tan A., Adelstein D.J., Rybicki L.A., Saxton J.P., Esclamado R.M., Wood B.G., et al. Ability of positron emission tomography to detect residual neck node disease in patients with head and neck squamous cell carcinoma after definitive chemoradiotherapy. Arch Otolaryngol Head Neck Surg 133 (2007) 435-440
23. Goguen L.A., Posner M.R., Tishler R.B., Wirth L.J., Norris C.M., Annino D.J., et al. Examining the need for neck dissection in the era of chemoradiation therapy for advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 132 (2006) 526-531
24. Nayak J.Y., Walvekar R., Andrade R.S., Daamem N., Lai S.Y., Argiris A., et al. Deferring planned neck dissection following chemoradiation for stage IV head and neck cancer: the utility of PET-CT. Laryngoscope 117 (2007) 2129-2134
25. Goerres G.W., Schmid D.T., Bandhauer F., Huguenin P.U., von Schulthess G.K., Schmid S., et al. Positron emission tomography in the early follow-up of advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 130 (2004) 105-109
26. Andrade R.S., Heron D.E., Degirmenci B., Filho P.H., Branstetter B.F., Seethala R.R., et al. Posttreatment assessment of response using FDG-PET/CT for patients treated with definitive radiation therapy for head and neck cancers. Int J Radiat Oncol Biol Phys 65 (2006) 1315-1322
27. Collins B.T., Gardner L.J., Verma A.K., Lowe V.J., Dunphy F.R., and Boyd J.H. Correlation of fine needle aspiration biopsy and fluoride-18 fluorodeoxyglucose positron emission tomography in the assessment of locally recurrent and metastatic head and neck neoplasia. Acta Cytol 42 (1998) 1325-1329
28. Lowe V.J., Boyd J.H., Dunphy F.R., Kim H., Dunleavy T., Collins B.T., et al. Surveillance for recurrent head and neck cancer using positron emission tomography. J Clin Oncol 18 (2000) 651-658
29. Salaun P.Y., Abgral R., Querellou S., Couturier O., Valette G., Bizais Y., et al. Does 18fluoro-fluorodeoxyglucose positron emission tomography improve recurrence detection in patients treated for head and neck squamous cell carcinoma with negative clinical follow-up?. Head Neck 29 (2007) 1115-1120
30. Kubota K., Yokoyama J., Yamaguchi K., Ono S., Quereshy A., Itoh M., et al. FDG-PET delayed imaging for the detection of head and neck cancer recurrence after radio-chemotherapy: comparison with MRI/CT. Eur J Nucl Med Mol Imaging 31 (2004) 590-595
31. Greven K.M., Williams III D.W., Keyes Jr. J.W., McGuirt W.F., Watson Jr. N.E., Randall M.E., et al. Positron emission tomography of patients with head and neck carcinoma before and after high dose irradiation. Cancer 74 (1994) 1355-1359
32. Lonneux M., Lawson G., Ide C., Bausart R., Remacle M., and Pauwels S. Positron emission tomography with fluorodeoxyglucose for suspected head and neck tumor recurrence in the symptomatic patient. Laryngoscope 110 (2000) 1493-1497
33. Kresnik E., Mikosch P., Gallowitsch H.J., Kogler D., Wiesser S., Heinish M., et al. Evaluation of head and neck cancer with 18F-FDG PET: a comparison with conventional methods. Eur J Nucl Med 28 (2001) 816-821
34. Nam S.Y., Lee S.W., Im K.C., Kim J.S., Kim S.Y., Choi S.H., et al. Early evaluation of the response to radiotherapy of patients with squamous cell carcinoma of the head and neck using 18FDG-PET. Oral Oncol 41 (2005) 390-395
35. Hermans R., Pameijer F.A., Mancuso A.A., Parsons J.T., and Mendenhall W.M. Laryngeal or hypopharyngeal squamous cell carcinoma: can follow-up CT after definitive radiation therapy be used to detect local failure earlier than clinical examination alone?. Radiology 214 (2000) 683-687
36. Pameijer F.A., Hermans R., Manusco A.A., Mendenhall W.M., Parsons J.T., Stringer S.P., et al. Pre- and post-radiotherapy computed tomography in laryngeal cancer: imaging-based prediction of local failure. Int J Radiat Oncol Biol Phys 45 (1999) 359-366
37. Brouwer J., Bodar E.J., de Bree R., Langendijk J.A., Castelijns J.A., Hoekstra O.S., et al. Detecting recurrent laryngeal carcinoma after radiotherapy: room for improvement?. Eur Arch Otorhinolaryngol 261 (2004) 417-422
38. Castelijns J.A., Hermans R., van den Brekel M.W., and Mukherji S.K. Imaging of laryngeal cancer. Semin Ultrasound CT MRI 19 (1998) 492-504
39. Hermans R. Post-treatment imaging of head and neck cancer. Cancer Imaging 4 (2004) S6-S15
40. Mukherji S.K., Mancuso A.A., Kotzur I.M., Mendenhall W.M., Kubilis P.S., Tart R.P., et al. Radiological appearance of the irradiated larynx Part II. Primary site response. Radiology 193 (1994) 149-154
41. Brouwer J., Hooft L., Hoekstra O.S., Riphagen I.I., Castelijns J.A., de Bree R., et al. Systematic review: accuracy of imaging tests in the diagnosis of recurrent laryngeal carcinoma after radiotherapy. Head Neck 30 (2008) 889-897
42. Putten L van d., de Bree R., Brouwer J., Hoekstra O.S., Comans E.F.I., and Leemans C.R. Interobserver variability in the assessment of FDG-PET for suspicion of recurrent laryngeal carcinoma after radiotherapy. Clin Otolaryngol 31 (2006) 575
43. de Bree R., van der Putten L., Hoekstra O.S., Kuik D.J., Uyl-de Groot C.A., van Tinteren H., et al. Towards a better selection for direct laryngoscopy under general anaesthesia in patients with suspicion of recurrent laryngeal carcinoma after radiotherapy?. Contemp Clin Trials 28 (2007) 705-712
44. 18 FDG-PET to select patients with suspicion of recurrent laryngeal carcinoma after radiotherapy for direct laryngoscopy under general anaesthesia. Radiother Oncol 87 (2008) 217-220
45. Ojiri H., Mendenhall W.M., and Mancuso A.A. CT findings at the primary site of oropharyngeal squamous cell carcinoma within 6-8 weeks after definitive radiotherapy as predictors of primary site control. Int J Radiat Oncol Biol Phys 52 (2002) 748-754
46. van den Broek G.B., Rasch C.R., Pameijer F.A., Peter E., van den Brekel M.W.M., and van den Balm A.J. Response measurement after intraarterial chemoradiation in advanced head and neck carcinoma: magnetic resonance imaging and evaluation under general anesthesia?. Cancer 106 (2006) 1722-1729
47. Kutler D.I., Patel S.G., and Shah J.P. The role of neck dissection following definitive chemoradiation. Oncology 18 (2004) 993-998
48. Robbins K.T., Ferlito A., Suarez C., Brizel D.M., Bradley P.E., Pellitteri P.K., et al. Is there a role for selective neck dissection after chemoradiation for head and neck cancer?. J Am Coll Surg 199 (2004) 913-916
49. Robbins K.T., Wong F.S., Kumar P., Hartsell W.F., Vieira F., Mullins B., et al. Efficacy of targeted chemoradiation and planned selective neck dissection to control bulky nodal disease in advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 125 (1999) 670-675
50. Balm A.J., Rasch C.R., Schornagel J.H., Hilgers F.J., Keus R.B., Schultze-Kool L., et al. High-dose superselective intra-arterial cisplatin and concomitant radiation (RADPLAT) for advanced head and neck cancer. Head Neck 26 (2004) 485-493
51. McHam S.A., Adelstein D.J., Rybicki L.A., Lavertu P., Esclamado R.M., Wood B.G., et al. Who merits a neck dissection after definitive chemoradiotherapy for N2-N3 squamous cell head and neck cancer?. Head Neck 25 (2003) 791-798
52. Farrag T.Y., Lin F.R., Cummings C.W., Koch W.M., Flint P.W., Califano J.A., et al. Neck management in patients undergoing postradiotherapy salvage laryngeal surgery for recurrent/persistent laryngeal cancer. Laryngoscope 116 (2006) 1864-1866
53. Liauw S.L., Mancuso A.A., Amdur R.J., Morris C.G., Villaret, and Werning J.W. Postradiotherapy neck dissection for lymph node-positive head and neck cancer: the use of computed tomography to manage the neck. J Clin Oncol 24 (2006) 1421-1427
54. Ojiri H., Mendenhall W.M., Stringer S.P., Johnson P.L., and Mancuso A.A. Post-RT CT results as a predictive model for the necessity of planned post-RT neck dissection in patients with cervical metastatic disease from squamous cell carcinoma. Int J Radiat Oncol Biol Phys 52 (2002) 420-428
55. Lee J.C., Kim J.S., Lee J.H., Nam S.Y., Choi S.H., Lee S.W., et al. F-18 FDG-PET as a routine surveillance tool for the detection of recurrent head and neck squamous cell carcinoma. Oral Oncol 43 (2007) 686-692
56. Abdel Razek A.A.K., Kandeel A.Y., Soliman N., El-shenshawy H.M., Kamel Y., Nada N., et al. Role of diffusion-weighted echo-planar MR imaging in differentation of residual or recurrent head and neck tumors and posttreatment changes. AJNR Am J Neuradiol 28 (2007) 1146-1152
57. Vandecaveye V., de Keyzer F., Nuyts S., Deraedt K., Dirix P., Hamaekers P., et al. Detection of head and neck squamous cell carcinoma with diffusion weighted MRI after (chemo)radiotherapy: correlation between radiologic and histopathologic findings. Int J Radiat Oncol Biol Phys 67 (2007) 960-971
58. Townsend D.W. Multimodality imaging of structure and function. Phys Med Biol 53 (2008) R1-R39
59. Halpern B.S., Yeom K., Fueger B.J., Lufkin R.B., Czernin J., and Allen-Auerbach M. Evaluation of suspected local recurrence in head and neck cancer: a comparison between PET and PET/CT for biopsy proven lesions. Eur J Radiol 62 (2007) 199-204
60. Fakhry N., Lussato D., Jacob T., Giorgi R., Giovanni A., and Zanaret M. Comparison between PET and PET/CT in recurrent head and neck cancer and clinical implications. Eur Arch Otorhinolaryngol 264 (2007) 531-538
61. de Boer J.R., Pruim J., Burlage F., Krikke A., Tiebosch A.T., Albers F.W., et al. Therapy evaluation of laryngeal carcinomas by tyrosine-PET. Head Neck 25 (2003) 634-644
62. Lindholm P., Leskinen-Kallio S., Grénman R., Lehikoinen P., Någren K., Terás M., et al. Evaluation of response to radiotherapy in head and neck cancer by positron emission tomography and [11C]methionine. Int J Radiat Oncol Biol Phys 32 (1995) 787-794
63. Cobben D.C.P., van der Laan B.F.A.M., Maas B., Vaalburg W., Suurmeijer A.J.H., Hoekstra H.J., et al. 18F-FLT PET for visualization of laryngeal cancer: comparison with 18F-FDG PET. J Nucl Med 45 (2004) 226-231